Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01GM115517-02
An unexpected signaling output for the tumor suppressor APC
National Institutes of Health
Grant: 5R01EY032149-03
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
National Institutes of Health
Grant: 1R01AI140539-01
Defining the functional interface between the ER and flaviviruses
National Institutes of Health
Grant: 5R01HL141759-03
Maintenance and expansion of long-term hematopoietic stem cells
National Institutes of Health
Grant: 1R01AI152362-01
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
National Institutes of Health
Grant: 1R21AI161678-01
Targeting Coronavirus through Nucleocapsid Phosphorylation
Fields of Study
Keywords
Sustainable Development Goals